OVID

Ovid Therapeutics Inc
NASDAQHEALTHCAREBIOTECHNOLOGY

Key Statistics

Market Cap
$461.00M
P/E Ratio
EPS
$-0.21
Beta
0.18
52W High
$3.10
52W Low
$0.27
50-Day MA
$2.57
200-Day MA
$1.75
Dividend Yield
Profit Margin
0.00%
Forward P/E
1.79
PEG Ratio
0.00

About Ovid Therapeutics Inc

Ovid Therapeutics Inc., a biopharmaceutical company, develops impactful medications for patients and families with neurological disorders in the United States. The company is headquartered in New York, New York.

Official WebsiteUSAFY End: December

Fundamentals

Revenue (TTM)$7.12M
Gross Profit (TTM)$7.12M
EBITDA$-47.57M
Operating Margin-670.00%
Return on Equity-18.80%
Return on Assets-19.40%
Revenue/Share (TTM)$0.08
Book Value$1.00
Price-to-Book2.32
Price-to-Sales (TTM)64.73
EV/Revenue44.6
EV/EBITDA-0.69
Quarterly Earnings Growth (YoY)0.00%
Quarterly Revenue Growth (YoY)845.00%
Shares Outstanding$186.64M
Float$161.29M
% Insiders6.99%
% Institutions56.43%

Historical Volatility

HV 10-Day
58.01%
HV 20-Day
52.07%
HV 30-Day
56.29%
HV 60-Day
78.12%
HV Rank

Volatility is currently expanding

Analyst Ratings

Consensus ($5.47 target)
10
Buy

More HEALTHCARE Stocks

Data last updated: 5/25/2026